ENVB vs. PSIL
ENVB (Enveric Biosciences Inc) is a stock, while PSIL (AdvisorShares Psychedelics ETF) is Health & Biotech Equities fund actively managed by AdvisorShares. Over the past 3 years, ENVB returned -85.14%/yr vs 11.93%/yr for PSIL. Their 0.29 correlation means their historical movements had little consistent relationship.
Performance
ENVB vs. PSIL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENVB achieves a -56.75% return, which is significantly lower than PSIL's 36.87% return.
ENVB
- 1D
- 9.79%
- 1M
- 8.28%
- 6M
- -46.05%
- YTD
- -56.75%
- 1Y
- -88.62%
- 3Y*
- -85.14%
- 5Y*
- -84.44%
- 10Y*
- -74.71%
- ALL TIME*
- -72.66%
PSIL
- 1D
- -1.14%
- 1M
- 1.16%
- 6M
- 40.80%
- YTD
- 36.87%
- 1Y
- 60.42%
- 3Y*
- 11.93%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -23.56%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $156.43K | $152.33K | $428.69K | |
| $992.95K | $1.18M | $917.29K |
ENVB vs. PSIL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ENVB Enveric Biosciences Inc | -56.75% | -94.37% | -72.43% | -37.50% | -95.53% | -64.91% |
PSIL AdvisorShares Psychedelics ETF | 36.87% | 74.55% | -19.50% | -25.12% | -67.24% | -42.72% |
Correlation
The correlation between ENVB and PSIL is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.23 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 2021 | 0.29 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENVB vs. PSIL — Risk / Return Rank
ENVB
PSIL
ENVB vs. PSIL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enveric Biosciences Inc (ENVB) and AdvisorShares Psychedelics ETF (PSIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ENVB | PSIL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.85 | ||
| Sortino ratioReturn per unit of downside risk | -2.89 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 1.23 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | 2.69 | -3.65 |
| Martin ratioReturn relative to average drawdown | -1.20 | 5.59 | -6.79 |
Loading charts...
Drawdowns
ENVB vs. PSIL - Drawdown Comparison
The maximum ENVB drawdown since its inception was -100.00%, which is greater than PSIL's maximum drawdown of -92.72%. Use the drawdown chart below to compare losses from any high point for ENVB and PSIL.
Loading charts...
Drawdown Indicators
| ENVB | PSIL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -92.72% | -7.28% |
Max Drawdown (1Y)Largest decline over 1 year | -92.70% | -20.38% | -72.32% |
Max Drawdown (3Y)Largest decline over 3 years | -99.75% | -61.25% | -38.50% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -73.38% | -26.62% |
Average DrawdownAverage peak-to-trough decline | -86.25% | -76.64% | -9.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 74.21% | 9.78% | +64.43% |
Volatility
ENVB vs. PSIL - Volatility Comparison
Enveric Biosciences Inc (ENVB) has a higher volatility of 17.33% compared to AdvisorShares Psychedelics ETF (PSIL) at 8.09%. This indicates that ENVB's price experiences larger fluctuations and is considered to be riskier than PSIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENVB | PSIL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.33% | 8.09% | +9.24% |
Volatility (6M)Calculated over the trailing 6-month period | 100.97% | 29.57% | +71.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 175.72% | 40.73% | +134.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 155.84% | 62.54% | +93.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 163.84% | 62.54% | +101.30% |
Dividends
ENVB vs. PSIL - Dividend Comparison
ENVB has not paid dividends to shareholders, while PSIL's dividend yield for the trailing twelve months is around 7.25%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PSIL AdvisorShares Psychedelics ETF | 7.25% | 10.95% | 1.49% | 0.24% | 2.91% |
Frequently Asked Questions
ENVB and PSIL have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (17.33%) compared to PSIL (8.09%). In terms of maximum drawdown, ENVB dropped -100.00% vs PSIL's -92.72%.
PSIL currently has the higher Sharpe Ratio (1.35 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENVB and PSIL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer